Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
Clinical trial NCT00777114 · COMPLETED
Trial details
- NCT number
- NCT00777114
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2012-12-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.